|Day Low/High||142.58 / 146.92|
|52 Wk Low/High||137.37 / 203.16|
Investment experts pick their favorites in the sector for 2022, ranging from diagnostics to medical devices and medical marijuana to drug development.
Traders should approach PKI from the long side at current levels.
The charts of the life sciences company suggest its stock could make a large upside move.
PKI should be an investor's favorite.
After the market close, we have a number of earnings reports coming at us, and one of my standard practices is to make a list as to which companies are reporting, and what's expected. This way, as the results hit the tape, I can perform a quick tria...
Investors can gain exposure to the high-flying cannabis industry without taking on undue risks.
Straying from these names could land you in quicksand as the 4th quarter begins.
Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.
It is all about perception, and here are strong names to pick up on market weakness.
Understanding the fundamentals of what is driving earnings is important but I like to look at the charts and indicators.
If you step out of the blinding spotlight, the truly rewarding buying opportunities become obvious.
Jim Cramer looks at why breaking up isn't hard to do, in a discussion with Mad Money Research Director Nicole Urken.
Robert Friel, CEO of PerkinElmer, says investors are recognizing the resiliency of the company's human health and environmental safety business lines.